Literature DB >> 4831319

Radioimmunoassay of parathyroid hormone in hypercalcemic patients with malignant disease.

R C Benson, B L Riggs, B M Pickard, C D Arnaud.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4831319     DOI: 10.1016/0002-9343(74)90810-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  26 in total

1.  Diagnosis and treatment of primary hyperparathyroidism.

Authors:  M A Dambacher; U Binswanger; J A Fischer
Journal:  Urol Res       Date:  1979-09

2.  Studies on the pathogenesis of cancer hypercalcemia.

Authors:  W P Laird Myers; R Bockman
Journal:  Trans Am Clin Climatol Assoc       Date:  1977

3.  Hypercalcemia and urinary excretion of cyclic AMP in bronchogenic carcinoma.

Authors:  G Francini; M Galli
Journal:  World J Surg       Date:  1977-07       Impact factor: 3.352

Review 4.  Prostaglandin-mediated hypercalcemia: a paraneoplastic syndrome.

Authors:  H W Seyberth
Journal:  Klin Wochenschr       Date:  1978-04-15

5.  Urinary cyclic AMP analyzed as a function of the serum calcium and parathyroid hormone in the idfferential diagnosis of hypercalcemia.

Authors:  J W Shaw; S B Oldham; L Rosoff; J E Bethune; M P Fichman
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

6.  Nononcologic disease in patients with cancer.

Authors:  B B Lowitz; R S Benjamin
Journal:  West J Med       Date:  1977-07

7.  Hepatic arterial embolization for malignant hypercalcemia in hepatocellular carcinoma.

Authors:  P Attali; D Houssin; A Roche; C Buffet; H Bismuth; J P Etienne
Journal:  Dig Dis Sci       Date:  1984-05       Impact factor: 3.199

8.  Human renal carcinoma cells produce hypercalcemia in the nude mouse and a novel protein recognized by parathyroid hormone receptors.

Authors:  G J Strewler; R D Williams; R A Nissenson
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

9.  Identification of adenylate cyclase-stimulating activity and cytochemical glucose-6-phosphate dehydrogenase-stimulating activity in extracts of tumors from patients with humoral hypercalcemia of malignancy.

Authors:  A F Stewart; K L Insogna; D Goltzman; A E Broadus
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

Review 10.  Hypercalcemia in malignancy.

Authors:  G J Strewler; R A Nissenson
Journal:  West J Med       Date:  1990-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.